These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2607527)

  • 1. Risk factor interactions for coronary heart disease.
    Mordasini RC
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():9-11; discussion 11-2. PubMed ID: 2607527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J; Chanu B; Bakir R; Sauvanet JP
    J Pharmacol; 1983; 14 Suppl 2():183-99. PubMed ID: 6138467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive therapy and the risk of coronary heart disease.
    Ames RP; Hill P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S206-12. PubMed ID: 6177958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary atherosclerosis and plasma lipoproteins: epidemiology and pathophysiologic considerations.
    Miller NE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S190-5. PubMed ID: 6177955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antihypertensive therapy on serum lipoproteins.
    Weidmann P; Gerber A; Mordasini R
    Hypertension; 1983; 5(5 Pt 2):III120-31. PubMed ID: 6138309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood lipids and antihypertensive drugs. The Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Pharmacol; 1983; 14 Suppl 2():217-20. PubMed ID: 6632918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
    Dickerman RD; McConathy WJ; Zachariah NY
    J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk factors and coronary heart disease.
    Berg K; Pedersen JC
    Scand J Clin Lab Invest Suppl; 1990; 202():82-5. PubMed ID: 2150112
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proatherothrombogenic effects of remnant lipoproteins on endothelial cells].
    Kugiyama K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():853-8. PubMed ID: 11347186
    [No Abstract]   [Full Text] [Related]  

  • 19. Apoproteins, lipoprotein subfractions, and the risk of coronary artery disease.
    Thompson WG
    South Med J; 1993 Feb; 86(2):194-200. PubMed ID: 8434292
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic polymorphism and plasma lipoproteins.
    Thompson G; Soutar A
    Nature; 1983 Feb; 301(5902):658. PubMed ID: 6828148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.